Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
- 31 January 1997
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 34 (1) , 33-38
- https://doi.org/10.1016/s0161-5890(97)00005-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptidesInternational Immunology, 1996
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Journal of Clinical Investigation, 1995
- Characterization of cDNA and Genomic Clones Encoding Human Myelin Oligodendrocyte GlycoproteinJournal of Neurochemistry, 1995
- Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model systemJournal of Neuroscience Research, 1995
- Extending the B7 (CD80) gene familyProtein Science, 1994
- Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.Journal of Clinical Investigation, 1993
- Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamilyJournal of Neuroscience Research, 1992
- The binding site for C1q on IgGNature, 1988
- Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)Journal of Neuroimmunology, 1987
- Recognition of IgG by Fc receptor and complement: Effects of glycosidase digestionBiochemical and Biophysical Research Communications, 1977